Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Dexamethasone via EyeGate II in Vitrectomy
NCT02644694Phase 1Completed
- Sponsor
- Kiora Pharmaceuticals
- Start
- Mar 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dexamethasone phosphate iontophoretic ophthalmic solution in post-operative inflammation, sponsored by Kiora Pharmaceuticals. Primary endpoints: Concentration of dexamethasone at Day 1 and Concentration of dexamethasone phosphate at Day 1. Started Mar 2016; status: completed.
02
Drugs
dexamethasone phosphate iontophoretic ophthalmic solution
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on NCT02644694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644694.